{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:23:05Z","timestamp":1787235785199,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical College Jagiellonian University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Introduction: Invasive prenatal testing with chromosomal microarray analysis after first-trimester screening is a relevant option but there is still debate regarding the indications. Therefore, we evaluated the prevalence of numerical chromosomal aberrations detected by classic karyotype and clinically relevant copy number variants (CNVs) in prenatal samples using array comparative genomic hybridization (aCGH) stratified to NT thickness: &lt;the 95th percentile, the 95th percentile\u20132.9 mm, 3.0\u20133.4 mm, 3.5\u20133.9 mm, 4.0\u20134.5 mm, and &gt;4.5 mm, and by the presence\/absence of associated structural anomalies detected by ultrasonography. Materials and Methods: Retrospective cohort study carried out at two tertiary Polish centers for prenatal diagnosis (national healthcare system) in central and south regions from January 2018 to December 2021. A total of 1746 prenatal samples were received. Indications for invasive prenatal testing included high risk of Down syndrome in the first-trimester combined test (n = 1484) and advanced maternal age (n = 69), and, in 193 cases, other reasons, such as parental request, family history of congenital defects, and genetic mutation carrier, were given. DNA was extracted directly from amniotic fluid (n = 1582) cells and chorionic villus samples (n = 164), and examined with classic karyotype and aCGH. Results: Of the entire cohort of 1746 fetuses, classical karyotype revealed numerical chromosomal aberrations in 334 fetuses (19.1%), and aCGH detected CNV in 5% (n = 87). The frequency of numerical chromosomal aberrations increased with NT thickness from 5.9% for fetuses with NT &lt; p95th to 43.3% for those with NT &gt; 4.5 mm. The highest rate of numerical aberrations was observed in fetuses with NT &gt; 4.5 mm having at least one structural anomaly (50.2%). CNVs stratified by NT thickness were detected in 2.9%, 2.9%, 3.5%, 4.3%, 12.2%, and 9.0% of fetuses with NT &lt; 95th percentile, 95th percentile\u20132.9 mm, 3.0\u20133.4 mm, 3.5\u20133.9 mm, 4.0\u20134.5 mm, and &gt;4.5 mm, respectively. After exclusion of fetuses with structural anomalies and numerical aberrations, aCGH revealed CNVs in 2.0% of fetuses with NT &lt; 95th percentile, 1.5% with NTp95\u20132.9 mm, 1.3% with NT 3.0\u20133.4 mm, 5.4% with NT 3.5\u20133.9 mm, 19.0% with NT 4.0\u20134.5 mm, and 14.8% with NT &gt; 4.5 mm. Conclusions: In conclusion, our study indicates that performing aCGH in samples referred to invasive prenatal testing after first-trimester screening provides additional clinically valuable information over conventional karyotyping, even in cases with normal NT and anatomy.<\/jats:p>","DOI":"10.3390\/diagnostics14192186","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:57:28Z","timestamp":1727672248000},"page":"2186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Array Comparative Genomic Hybridization (aCGH) Results among Patients Referred to Invasive Prenatal Testing after First-Trimester Screening: A Comprehensive Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4728-275X","authenticated-orcid":false,"given":"Anna","family":"W\u00f3jtowicz","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Perinatology, Jagiellonian University Medical College, 31-501 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-063X","authenticated-orcid":false,"given":"Katarzyna","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Institute of Mother and Child, 30-663 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Szewczyk","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Jagiellonian University Medical College, 30-551 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Madetko-Talowska","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Jagiellonian University Medical College, 30-551 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-5528","authenticated-orcid":false,"given":"Wojciech","family":"W\u00f3jtowicz","sequence":"additional","affiliation":[{"name":"Information Technology Systems Department, Faculty of Management and Social Communication, Jagiellonian University, 30-348 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Huras","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Perinatology, Jagiellonian University Medical College, 31-501 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-7050","authenticated-orcid":false,"given":"Miros\u0142aw","family":"Bik-Multanowski","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Jagiellonian University Medical College, 30-551 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowakowska","family":"Beata","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Institute of Mother and Child, 30-663 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.304.6831.867","article-title":"Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy","volume":"304","author":"Nicolaides","year":"1992","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10\u201314 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajog.2004.12.093","article-title":"Increased nuchal translucency with normal karyotype","volume":"192","author":"Souka","year":"2005","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/uog.15961","article-title":"Increased nuchal translucency thickness and risk of neurodevelopmental disorders","volume":"49","author":"Hellmuth","year":"2017","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"675.e1","DOI":"10.1016\/j.ajog.2014.06.025","article-title":"Risk of selected structural abnormalities in infants after increased nuchal translucency measurement","volume":"211","author":"Baer","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/uog.5299","article-title":"A mixture model of nuchal translucency thickness in screening for chromosomal defects","volume":"31","author":"Wright","year":"2008","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/den224","article-title":"Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A","volume":"23","author":"Kagan","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.2637","article-title":"Screening for fetal aneuploidies at 11 to 13 weeks","volume":"31","author":"Nicolaides","year":"2011","journal-title":"Prenat. Diagn."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/uog.14880","article-title":"Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: A systematic review and meta-analysis","volume":"46","author":"Grande","year":"2015","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_10","unstructured":"(2009). Polish Gynaecological Society guideline on prenatal diagnosis. Ginekol. Pol., 80, 390\u2013393."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/uog.17421","article-title":"Cut-off value of nuchal translucency as indication for chromosomal microarray analysis","volume":"50","author":"Maya","year":"2017","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00404-017-4459-9","article-title":"Principles of first trimester screening in the age of non-invasive prenatal diagnosis: Screening for chromosomal abnormalities","volume":"296","author":"Kagan","year":"2017","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands","volume":"105","author":"Sistermans","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13039-016-0279-z","article-title":"Enlarged NT (\u22653.5 mm) in the first trimester\u2014Not all chromosome aberrations can be detected by NIPT","volume":"9","author":"Srebniak","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/uog.13384","article-title":"Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH?","volume":"43","author":"Huang","year":"2014","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Committee on Genetics and the Society for Maternal-Fetal Medicine (2016). Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obs. Gynecol., 128, e262\u2013e268.","DOI":"10.1097\/AOG.0000000000001817"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41431-018-0244-x","article-title":"European guidelines for constitutional cytogenomic analysis","volume":"27","author":"Silva","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_19","unstructured":"(2012). Polish Gynecological Society\u2014Ultrasound Section Guidelines on ultrasound screening in uncomplicated pregnancy (2 December 2011). Ginekol. Pol., 83, 309\u2013315."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/uog.12342","article-title":"ISUOG practice guidelines: Performance of first-trimester fetal ultrasound scan","volume":"41","author":"Salomon","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kowalczyk, K., Bartnik-G\u0142aska, M., Smyk, M., Plaskota, I., Bernaciak, J., K\u0119dzior, M., Wi\u015bniowiecka-Kowalnik, B., Jakub\u00f3w-Durska, K., Braun-Walicka, N., and Barczyk, A. (2021). Prenatal Diagnosis by Array Comparative Genomic Hybridization in Fetuses with Cardiac Abnormalities. Genes, 12.","DOI":"10.3390\/genes12122021"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"W\u00f3jtowicz, A., Madetko-Talowska, A., W\u00f3jtowicz, W., Szewczyk, K., Huras, H., and Bik-Multanowski, M. (2022). Cardiovascular Anomalies among 1005 Fetuses Referred to Invasive Prenatal Testing-A Comprehensive Cohort Study of Associated Chromosomal Aberrations. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191610019"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ejhg.2013.125","article-title":"Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic)","volume":"22","author":"Claustres","year":"2013","journal-title":"Eur. J. Hum. Gen."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13353-017-0407-4","article-title":"Clinical interpretation of copy number variants in the human genome","volume":"58","author":"Nowakowska","year":"2017","journal-title":"J. Appl. Gen."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajmg.c.31697","article-title":"Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong","volume":"181","author":"Cheng","year":"2019","journal-title":"Am. J. Med. Gen. Part. C Semin. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/ajo.12590","article-title":"Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015","volume":"57","author":"Johnson","year":"2017","journal-title":"Aust. N. Z. J. Obs. Gynaecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/pd.5590","article-title":"Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?","volume":"40","author":"Bardi","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/pd.3943","article-title":"Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound","volume":"32","author":"Shaffer","year":"2012","journal-title":"Prenat. Diagn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/uog.12429","article-title":"Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: Results from over 1000 consecutive cases","volume":"41","author":"Scott","year":"2013","journal-title":"Ultrasound Obs. Gynecol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/uog.12464","article-title":"Use of prenatal chromosomal microarray: Prospective cohort study and systematic review and meta-analysis","volume":"41","author":"Hillman","year":"2013","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pd.5877","article-title":"Prenatal array comparative genomic hybridization in a well-defined cohort of high-risk pregnancies. A 3-year implementation results in a public tertiary academic referral hospital","volume":"41","author":"Tanner","year":"2021","journal-title":"Prenat. Diagn."},{"key":"ref_32","first-page":"285","article-title":"Array study in fetuses with nuchal translucency above the 95th percentile: A 4-year observational single-centre study","volume":"307","author":"Calero","year":"2023","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/uog.18928","article-title":"Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: A French multicenter study","volume":"52","author":"Egloff","year":"2018","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/aogs.13877","article-title":"Nuchal translucency of 3.0\u20133.4 mm an indication for NIPT or microarray? Cohort analysis and literature review","volume":"99","author":"Petersen","year":"2020","journal-title":"Acta Obs. Gynecol. Scand."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2021.03.050","article-title":"Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: Results from the Victorian Perinatal Record Linkage study","volume":"225","author":"Hui","year":"2021","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/AOG.0000000000004195","article-title":"Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses with Nuchal Translucency From 3.0 mm through 3.4 mm","volume":"137","author":"Singer","year":"2021","journal-title":"Obs. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1002\/mgg3.811","article-title":"Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype","volume":"7","author":"Su","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000506095","article-title":"Genetic examination for fetuses with increased fetal nuchal translucency by genomic technology","volume":"160","author":"Xue","year":"2020","journal-title":"Cytogenet. Genome Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/uog.17533","article-title":"Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: Systematic review and meta-analysis","volume":"51","author":"Srebniak","year":"2018","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijgo.14637","article-title":"Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational study","volume":"161","author":"Spataro","year":"2023","journal-title":"Int. J. Gynaecol. Obs."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:07:27Z","timestamp":1760112447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":40,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["diagnostics14192186"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14192186","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}